Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001804567-25-000006
Filing Date
2025-09-15
Accepted
2025-09-15 17:39:00
Documents
1
Period of Report
2025-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757972337.html 4  
1 FORM 4 wk-form4_1757972337.xml 4 7206
  Complete submission text file 0001804567-25-000006.txt   8702
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Mottola Frank (Reporting) CIK: 0001804567 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 251315218